Yi Ren
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Molecular Medicine top 5%
- Curcumin's Biomedical Applications
Papers in
-
- Breast Cancer Treatment Studies 19
- Oncology 19
- Global Cancer Incidence and Screening 7
- Cancer survivorship and care 4
- Co-authors
- Rachel A. Greenup (16 shared papers)Oluwadamilola M. Fayanju (16 shared papers)Samantha M. Thomas (15 shared papers)Laura H. Rosenberger (13 shared papers)Jennifer K. Plichta (12 shared papers)Terry Hyslop (13 shared papers)E. Shelley Hwang (7 shared papers)Yixue Xue (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)PLoS ONE (5 papers)Cancer (3 papers)Annals of Surgical Oncology (3 papers)Breast Cancer Research and Treatment (3 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Yi Ren
60 papers receiving 864 citations
Peers
Comparison fields: 5 of 98
- Cancer Research 371
- Molecular Medicine 92
- Oncology 336
- Pathology and Forensic Medicine 201
- Molecular Biology 266
Countries citing papers authored by Yi Ren
This map shows the geographic impact of Yi Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Ren more than expected).
Fields of papers citing papers by Yi Ren
This network shows the impact of papers produced by Yi Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Ren. The network helps show where Yi Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 195 | |
| 2 | 2018 | 147 | |
| 3 | 2018 | 65 | |
| 4 | 2019 | 38 | |
| 5 | Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines. | 2004 | 35 |
| 6 | 2020 | 31 | |
| 7 | 2020 | 21 | |
| 8 | Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma. | 2004 | 20 |
| 9 | 2019 | 18 | |
| 10 | 2019 | 18 | |
| 11 | 2017 | 17 | |
| 12 | 2019 | 14 | |
| 13 | 2015 | 14 | |
| 14 | 2021 | 13 | |
| 15 | 2019 | 13 | |
| 16 | 2018 | 13 | |
| 17 | 2020 | 13 | |
| 18 | 2019 | 12 | |
| 19 | 2023 | 10 | |
| 20 | 2020 | 10 |
About Yi Ren
Yi Ren is a scholar working on Cancer Research, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 65 papers that have together received 878 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (19 papers), Breast Lesions and Carcinomas (9 papers), Global Cancer Incidence and Screening (7 papers), Breast Implant and Reconstruction (5 papers), Economic and Financial Impacts of Cancer (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), RNA modifications and cancer (4 papers) and Cancer survivorship and care (4 papers). The work is most often cited by research in Cancer Research (371 citations), Molecular Medicine (92 citations), Oncology (336 citations), Pathology and Forensic Medicine (201 citations) and Molecular Biology (266 citations). Yi Ren has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Rachel A. Greenup, Oluwadamilola M. Fayanju, Samantha M. Thomas, Laura H. Rosenberger, Jennifer K. Plichta, Terry Hyslop, E. Shelley Hwang, Yixue Xue, Chengliang Yang and Zhen Li. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE, Cancer, Annals of Surgical Oncology and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.